ClinicalTrials.gg
CompletedNCT07882771SJW-CHX-RMEUpdated Oct 20, 2026

St. John's Wort Oil Versus Chlorhexidine Mouthwash for Gingival Problems After Rapid Maxillary Expansion

An interventional study of St. John's Wort Oil and Chlorhexidine in Gingivitis and Maxillary Transversal Deficiency, sponsored by Yuzuncu Yil University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 11 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Yuzuncu Yil University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 4 months after the study started (first participant enrolled Jun 2019, registered Oct 2026).
Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
11 Years to 16 Years
Sex
All
01

Study summary

The goal of this clinical trial was to learn whether St. John's wort (Hypericum perforatum) oil helps gum healing in children and adolescents aged 11 to 16 years after treatment with a rapid maxillary expansion appliance. This appliance widens the upper jaw, but it covers a large part of the palate and makes cleaning difficult, which can cause gum redness, bleeding, swelling and pain after the appliance is removed.

The main questions it aimed to answer were:

Does St. John's wort oil improve gum health after the appliance is removed? Does it reduce pain in the days after appliance removal?

Researchers compared St. John's wort oil with chlorhexidine mouthwash, a commonly used oral antiseptic, and with a control group that used no antiseptic product.

Participants:

Were randomly assigned to one of three groups after removal of the expansion appliance Used St. John's wort oil as a mouthrinse or chlorhexidine three times a day for 7 days, or used no product (control group) Had their gums examined before the appliance was placed, when it was removed, and 7, 14 and 30 days later Recorded their pain level on a 0-10 scale on several days after appliance removal

02

Conditions studied

  • Gingivitis
  • Maxillary Transversal Deficiency

Browse trials for

Keywords

  • Rapid maxillary expansion
  • Hypericum perforatum
  • St. John's wort oil
  • Chlorhexidine
  • Gingival inflammation
  • Orthodontic appliance
03

In context

Gingivitis

609 studies on the registry are indexed under Gingivitis; 107 are open to participants now.

This study's enrollment of 60 is close to the median of 63 across 494 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

Yuzuncu Yil University is the lead sponsor of 75 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 11 and 16 years Maxillary transverse deficiency with bilateral posterior crossbite requiring rapid maxillary expansion No systemic disease Ability to read and understand the informed consent form Voluntary participation with written informed consent from the participant and parent/legal guardian

Exclusion criteria

Exclusion Criteria:

  • Presence of systemic disease Severe facial deformity Not meeting the inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    St. John's Wort Oil

    Participants rinsed with St. John's wort (Hypericum perforatum) oil three times daily for 7 days after removal of the rapid maxillary expansion appliance.

    Other: St. John's Wort Oil

  • Active comparator
    Chlorhexidine

    Participants rinsed with chlorhexidine mouthwash three times daily for 7 days after removal of the rapid maxillary expansion appliance.

    Drug: Chlorhexidine

  • No intervention
    Control

    Participants received no mouthwash after removal of the rapid maxillary expansion appliance.

Interventions

  • OtherSt. John's Wort Oil

    St. John's wort (Hypericum perforatum) oil was used as a mouthrinse three times daily for 7 days, starting after removal of the rapid maxillary expansion appliance. The product was dispensed in an identical, unlabeled bottle.

  • Chlorhexidine gluconate mouthwash was used as a mouthrinse three times daily for 7 days, starting after removal of the rapid maxillary expansion appliance. The product was dispensed in an identical, unlabeled bottle.

06

What researchers measure

Primary outcomes

  1. Gingival Index (Löe & Silness)

    Gingival inflammation was assessed using the Löe and Silness gingival index (score 0-3; 0 = normal gingiva, 3 = severe inflammation with tendency to spontaneous bleeding). Higher scores indicate worse gingival health.

    Time frame: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

Secondary outcomes

  1. Plaque Index (Silness & Löe)

    Plaque accumulation was assessed using the Silness and Löe plaque index (score 0-3; 0 = no plaque, 3 = abundant plaque). Higher scores indicate more plaque accumulation.

    Time frame: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

  2. Bleeding on Probing

    Percentage of sites showing bleeding within 15 seconds after gentle probing. Higher percentages indicate more gingival inflammation.

    Time frame: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

  3. Pain Intensity (Visual Analogue Scale)

    Pain was self-reported by participants on a 10 cm visual analogue scale (0 = no pain, 10 = worst imaginable pain). Higher scores indicate more pain.

    Time frame: Days 2, 4, 5 and 6 after appliance removal

07

Study locations

1 site
  • Van Yuzuncu Yil University Faculty of Dentistry, Department of Orthodontics
    Van, Van 65080, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available because the participants were minors and the informed consent forms did not include permission for public data sharing. De-identified data are available from the corresponding author upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2019 to primary completion in Nov 2020, 17 months.

Of 203 non-industry interventional studies with no phase under Gingivitis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 19. This study's 17 months is above that.

Counting every sponsor, half of 255 studies reached it within 7 months; a quarter within 3 and three quarters within 16.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2026
First posted
Oct 20, 2026
StartActual
Jun 10, 2019
Primary completionActual
Nov 10, 2020
CompletionActual
Nov 10, 2020
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07882771
Lead sponsor
Yuzuncu Yil University
Responsible party
Gönül Dinç (assist. prof., Yuzuncu Yil University) — Principal investigator
First posted
Oct 20, 2026
Start date
Jun 10, 2019
Primary completion
Nov 10, 2020
Completion
Nov 10, 2020
Last update
Oct 20, 2026

Study contacts

SAADET ÇINARSOY CİĞERİM, assoc. prof.
principal investigator · Yuzuncu Yil University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion